New directions in the treatment of opioid withdrawal.
Srivastava AB, Mariani JJ, Levin FR.
Lancet. 2020 Jun 20;395(10241):1938-1948. doi: 10.1016/S0140-6736(20)30852-7.
The fragile state of opioid withdrawal.
Wong W.
Sci Signal. 2023 Feb 14;16(772):eadh0620. doi: 10.1126/scisignal.adh0620. Epub 2023 Feb 14.
Neonatal Abstinence Syndrome.
Jansson LM, Patrick SW.
Pediatr Clin North Am. 2019 Apr;66(2):353-367. doi: 10.1016/j.pcl.2018.12.006.
Review article: Effective management of opioid withdrawal symptoms: A gateway to opioid dependence treatment.
Kosten TR, Baxter LE.
Am J Addict. 2019 Feb;28(2):55-62. doi: 10.1111/ajad.12862. Epub 2019 Jan 31.
Buprenorphine Pharmacology Review: Update on Transmucosal and Long-acting Formulations.
Coe MA, Lofwall MR, Walsh SL.
J Addict Med. 2019 Mar/Apr;13(2):93-103. doi: 10.1097/ADM.0000000000000457.
Low Dose Initiation of Buprenorphine: A Narrative Review and Practical Approach.
Cohen SM, Weimer MB, Levander XA, Peckham AM, Tetrault JM, Morford KL.
J Addict Med. 2022 Jul-Aug 01;16(4):399-406. doi: 10.1097/ADM.0000000000000945. Epub 2021 Dec 23.
Historical Review: Opiate Addiction and Opioid Receptors.
Wang S.
Cell Transplant. 2019 Mar;28(3):233-238. doi: 10.1177/0963689718811060. Epub 2018 Nov 13.
Clinical pharmacology of opioids for pain.
Inturrisi CE.
Clin J Pain. 2002 Jul-Aug;18(4 Suppl):S3-13. doi: 10.1097/00002508-200207001-00002.
Opioid withdrawal: role in addiction and neural mechanisms.
Monroe SC, Radke AK.
Psychopharmacology (Berl). 2023 Jul;240(7):1417-1433. doi: 10.1007/s00213-023-06370-2. Epub 2023 May 10.
Extended-Release 7-Day Injectable Buprenorphine for Patients With Minimal to Mild Opioid Withdrawal.
D'Onofrio G, Herring AA, Perrone J, Hawk K, Samuels EA, Cowan E, Anderson E, McCormack R, Huntley K, Owens P, Martel S, Schactman M, Lofwall MR, Walsh SL, Dziura J, Fiellin DA.
JAMA Netw Open. 2024 Jul 1;7(7):e2420702. doi: 10.1001/jamanetworkopen.2024.20702.
